TransMedics (TMDX) Accounts Payables (2018 - 2026)

TransMedics' Accounts Payables history runs 9 years deep, the most recent figure standing at $11.2 million for Q1 2026.

• In Q1 2026, Accounts Payables rose 5.25% year-over-year to $11.2 million; the TTM figure through Mar 2026 stood at $11.2 million (up 5.25% YoY), while the FY2025 annual figure was $10.4 million, up 0.56% from the prior year.
• Accounts Payables was $11.2 million for Q1 2026 at TransMedics, up from $10.4 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $13.1 million in Q3 2024 to a low of $2.9 million in Q1 2022.
• Historically, Accounts Payables has averaged $8.9 million across 5 years, with a median of $10.3 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Accounts Payables slumped 49.77% in 2022, then surged 316.75% in 2023.
• A 5-year view of Accounts Payables shows it stood at $3.3 million in 2022, then soared by 280.63% to $12.7 million in 2023, then retreated by 19.07% to $10.3 million in 2024, then grew by 0.56% to $10.4 million in 2025, then rose by 7.74% to $11.2 million in 2026.
• The last three Accounts Payables figures came in at $11.2 million (Q1 2026), $10.4 million (Q4 2025), and $12.2 million (Q3 2025), per Business Quant data.